| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_911b4acade8263835623b6e69bff6673 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2012-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2855ce40eca0b6407f598564d54fb60e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b1accdeb8b4f7b046198161b5e22250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf7b5300507e13e8550a19724e32f46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea70bf866ef8b56d7c610d40344d21a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fdda00e3176ab2ecd6b1f5f68887503 |
| publicationDate |
2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140072035-A |
| titleOfInvention |
Mutations in the epidermal growth factor receptor gene |
| abstract |
The present invention is directed to a method of inhibiting the growth of an epithelial growth factor receptor gene (e. G., ≪ RTI ID = 0.0 > glioblastoma < / RTI >Lt; RTI ID = 0.0 > mutations. ≪ / RTI > The present invention includes a kit for predicting the response of an object to a therapeutic regimen including cetuximab and / or panithuimab, as well as peptide sequences, primers and probes for detecting such mutations. In particular, the present invention is useful in therapeutic treatments applicable to metastatic colorectal cancer and head and neck cancer. |
| priorityDate |
2011-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |